TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Physical Activity and Academic Achievement Across the Curriculum (A+PAAC)
Brief Summary: There is currently considerable interest in both improving academic achievement (No Child Left Behind) and reducing the rates of obesity and its associated negative health consequences in elementary school students. Increased physical activity (PA) offers a potential intervention to address both issues. Evidence is available which suggests an association of PA with both academic achievement and obesity, and an association between obesity and academic achievement.

To provide increased PA while maintaining academic instruction time, we developed a program we call "Physical Activity Across the Curriculum" (PAAC) in which regular classroom teachers were trained to deliver academic lessons using moderate to vigorous physical activity (MVPA) for 20 minutes/d, 5 days/wk. This study is looking to compare academic achievement between students in elementary schools that participate in academic lessons taught through MVPA (PAAC) to students that do not (CON).


Options:
A: Arm Label: A+PAAC; Type: EXPERIMENTAL; Interventions: Behavioral: A+PAAC | Arm Label: CON; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CON | Intervention Type: BEHAVIORAL; Name: A+PAAC; Assigned to Arm(s): A+PAAC | Intervention Type: BEHAVIORAL; Name: CON; Assigned to Arm(s): CON
B: Arm Label: Nutrition and Physical Activity; Type: EXPERIMENTAL; Interventions: Behavioral: The Food Friends | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The Food Friends; Assigned to Arm(s): Nutrition and Physical Activity
C: Arm Label: Parenting Insight; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Parenting Insights | Arm Label: Child Safety Insights; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Child Safety Insights | Intervention Type: BEHAVIORAL; Name: Child Safety Insights; Assigned to Arm(s): Child Safety Insights | Intervention Type: BEHAVIORAL; Name: Parenting Insights; Assigned to Arm(s): Parenting Insight
D: Arm Label: Education Home Visits; Type: EXPERIMENTAL; Interventions: Other: Education Home Visits | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Education Home Visits; Assigned to Arm(s): Education Home Visits

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Growth of Infants Fed an Elemental Medical Food
Brief Summary: Effects on weight will be monitored in healthy infant subjects consuming assigned infant formulas.


Options:
A: Arm Label: parenteral nutrition solution; Type: OTHER; Interventions: Drug: Ped3CB | Intervention Type: DRUG; Name: Ped3CB; Assigned to Arm(s): parenteral nutrition solution
B: Arm Label: Amix; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Amix | Intervention Type: DIETARY_SUPPLEMENT; Name: Amix; Assigned to Arm(s): Amix
C: Arm Label: Reference group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard infant formula | Arm Label: Formula with 50% Osteopontin; Type: ACTIVE_COMPARATOR; Interventions: Other: Infant formula supplemented with bovine milk Osteopontin | Arm Label: Formula with 100% Osteopontin; Type: ACTIVE_COMPARATOR; Interventions: Other: Infant formula supplemented with bovine milk Osteopontin | Intervention Type: OTHER; Name: Infant formula supplemented with bovine milk Osteopontin; Assigned to Arm(s): Formula with 100% Osteopontin, Formula with 50% Osteopontin | Intervention Type: OTHER; Name: Standard infant formula; Assigned to Arm(s): Control formula
D: Arm Label: Control Study Formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Control Study Formula | Arm Label: Experimental Study Formula; Type: EXPERIMENTAL; Interventions: Other: Experimental Study Formula | Intervention Type: OTHER; Name: Control Study Formula; Assigned to Arm(s): Control Study Formula | Intervention Type: OTHER; Name: Experimental Study Formula; Assigned to Arm(s): Experimental Study Formula

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: In the present study the investigators intend to investigate analgesic and sensory effects of a capsaicin patch 8 %(Qutenza) in patients with severe post-herniotomy pain and sensory abnormalities in the skin.


Options:
A: Intervention Type: DRUG; Name: NGX-4010; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Capsaicin Dermal Patch; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: NGX-4010; Assigned to Arm(s): N/A
D: Arm Label: capsaicin patch; Type: ACTIVE_COMPARATOR; Interventions: Drug: capsaicin patch (qutenza) | Arm Label: placebo patch; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: capsaicin patch (qutenza); Assigned to Arm(s): capsaicin patch | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo patch

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Predictors of Poor Immune Response to Rotavirus Vaccine in Infants
Brief Summary: This will be a randomized study with the primary objective of assessing the impact of withholding versus encouraging breastfeeding on the immunogenicity of Rotarix® in infants.

Enrolled subjects will all be administered Rotarix®, at ages 6 to 7 weeks, and at10 -14 weeks. The subjects will be randomized into one of the two study arms. In one of the group caregivers will be advised to breastfeed immediately prior to and after each dose of the vaccine while in the other group caregivers will be advised to withhold breastfeeding for 30 minutes before and after each dose of the vaccine. The other childhood vaccines i.e. OPV and Pentavalent will be administered at least 30 minutes after administration of Rotarix®, The enrolled subjects will be followed up for 4 weeks after the 2nd dose of Rotarix®.


Options:
A: Arm Label: Rotavin; Type: EXPERIMENTAL; Interventions: Drug: Rotavin | Intervention Type: DRUG; Name: Rotavin; Assigned to Arm(s): Rotavin
B: Arm Label: V260 with staggered EPI; Type: EXPERIMENTAL; Interventions: Biological: V260, Biological: OPV, Biological: DTaP | Arm Label: Placebo with staggered EPI; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo to V260, Biological: OPV, Biological: DTaP | Arm Label: V260 with concomitant EPI; Type: EXPERIMENTAL; Interventions: Biological: V260, Biological: OPV, Biological: DTaP | Arm Label: Placebo with concomitant EPI; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo to V260, Biological: OPV, Biological: DTaP | Intervention Type: BIOLOGICAL; Name: V260; Assigned to Arm(s): V260 with concomitant EPI, V260 with staggered EPI | Intervention Type: BIOLOGICAL; Name: Placebo to V260; Assigned to Arm(s): Placebo with concomitant EPI, Placebo with staggered EPI | Intervention Type: BIOLOGICAL; Name: OPV; Assigned to Arm(s): Placebo with concomitant EPI, Placebo with staggered EPI, V260 with concomitant EPI, V260 with staggered EPI | Intervention Type: BIOLOGICAL; Name: DTaP; Assigned to Arm(s): Placebo with concomitant EPI, Placebo with staggered EPI, V260 with concomitant EPI, V260 with staggered EPI
C: Intervention Type: BIOLOGICAL; Name: Rotavirus (vaccine); Assigned to Arm(s): N/A
D: Arm Label: Breastfeeding; Type: OTHER; Interventions: Other: Breastfeeding | Arm Label: Breastfeeding Withheld; Type: ACTIVE_COMPARATOR; Interventions: Other: Breastfeeding | Intervention Type: OTHER; Name: Breastfeeding; Assigned to Arm(s): Breastfeeding, Breastfeeding Withheld

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Predictors of Poor Immune Response to Rotavirus Vaccine in Infants
Brief Summary: This will be a randomized study with the primary objective of assessing the impact of withholding versus encouraging breastfeeding on the immunogenicity of Rotarix® in infants.

Enrolled subjects will all be administered Rotarix®, at ages 6 to 7 weeks, and at10 -14 weeks. The subjects will be randomized into one of the two study arms. In one of the group caregivers will be advised to breastfeed immediately prior to and after each dose of the vaccine while in the other group caregivers will be advised to withhold breastfeeding for 30 minutes before and after each dose of the vaccine. The other childhood vaccines i.e. OPV and Pentavalent will be administered at least 30 minutes after administration of Rotarix®, The enrolled subjects will be followed up for 4 weeks after the 2nd dose of Rotarix®.


Options:
A: Intervention Type: BIOLOGICAL; Name: HRV vaccine; Assigned to Arm(s): N/A
B: Arm Label: Breastfeeding; Type: OTHER; Interventions: Other: Breastfeeding | Arm Label: Breastfeeding Withheld; Type: ACTIVE_COMPARATOR; Interventions: Other: Breastfeeding | Intervention Type: OTHER; Name: Breastfeeding; Assigned to Arm(s): Breastfeeding, Breastfeeding Withheld
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: RotaTeq™ - Rotavirus Vaccine, Live, Oral, Pentavalent | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Comparator: Placebo | Intervention Type: BIOLOGICAL; Name: RotaTeq™ - Rotavirus Vaccine, Live, Oral, Pentavalent; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Comparator: Placebo; Assigned to Arm(s): 2
D: Arm Label: Rotavin; Type: EXPERIMENTAL; Interventions: Drug: Rotavin | Intervention Type: DRUG; Name: Rotavin; Assigned to Arm(s): Rotavin

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Brief Summary: The purpose of this study is to assess the efficacy and safety of MK-8237 (SCH 900237) in the treatment of House Dust Mite (HDM)-Induced Allergic Rhinitis/Rhinoconjunctivitis (AR/ARC) in children and adults.

The primary hypothesis of this study is that administration of MK-8237, compared to placebo, results in significant reduction in the average total combined rhinitis score (TCRS).


Options:
A: Intervention Type: DRUG; Name: ALK HDM tablet; Assigned to Arm(s): N/A
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: MK-8237 6 Developmental Units (DU); Type: EXPERIMENTAL; Interventions: Drug: MK-8237 6 DU | Arm Label: MK-8237 12 DU; Type: EXPERIMENTAL; Interventions: Drug: MK-8237 12 DU | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: MK-8237 6 DU; Assigned to Arm(s): MK-8237 6 Developmental Units (DU) | Intervention Type: DRUG; Name: MK-8237 12 DU; Assigned to Arm(s): MK-8237 12 DU
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Staloral | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Staloral | Intervention Type: DRUG; Name: Staloral; Assigned to Arm(s): 1, 2
D: Arm Label: MK-8237; Type: EXPERIMENTAL; Interventions: Biological: MK-8237 tablets, Drug: Rescue Medication: Self-Injectable Epinephrine, Drug: Rescue Medication: Loratadine tablets, Drug: Rescue Medication: Olopatadine ophthalmic drops, Drug: Rescue Medication: Mometasone furoate nasal spray | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo tablets, Drug: Rescue Medication: Self-Injectable Epinephrine, Drug: Rescue Medication: Loratadine tablets, Drug: Rescue Medication: Olopatadine ophthalmic drops, Drug: Rescue Medication: Mometasone furoate nasal spray | Intervention Type: BIOLOGICAL; Name: MK-8237 tablets; Assigned to Arm(s): MK-8237 | Intervention Type: BIOLOGICAL; Name: Placebo tablets; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Rescue Medication: Self-Injectable Epinephrine; Assigned to Arm(s): MK-8237, Placebo | Intervention Type: DRUG; Name: Rescue Medication: Loratadine tablets; Assigned to Arm(s): MK-8237, Placebo | Intervention Type: DRUG; Name: Rescue Medication: Olopatadine ophthalmic drops; Assigned to Arm(s): MK-8237, Placebo | Intervention Type: DRUG; Name: Rescue Medication: Mometasone furoate nasal spray; Assigned to Arm(s): MK-8237, Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The effect of axillary lavage with a gentamicin solution before wound closure will reduce the drainage volume and subsequently day of drainage removal.


Options:
A: Arm Label: intraoperative colon lavage; Type: EXPERIMENTAL; Interventions: Procedure: intraoperative colon lavage with primary anastomosis | Arm Label: stent and deferred surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intraoperative colon lavage with primary anastomosis | Intervention Type: PROCEDURE; Name: intraoperative colon lavage with primary anastomosis; Assigned to Arm(s): intraoperative colon lavage, stent and deferred surgery
B: Arm Label: Gentamicin lavage; Type: EXPERIMENTAL; Interventions: Drug: Axillary lavage with gentamicin solution | Arm Label: Normal saline lavage; Type: ACTIVE_COMPARATOR; Interventions: Drug: Axillary lavage with gentamicin solution | Intervention Type: DRUG; Name: Axillary lavage with gentamicin solution; Assigned to Arm(s): Gentamicin lavage, Normal saline lavage
C: Arm Label: Irrigation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Normal Saline Irrigation | Arm Label: No Irrigation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Normal Saline Irrigation; Assigned to Arm(s): Irrigation
D: Arm Label: Saline, gravity flow; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Saline Solution, Procedure: Gravity Flow Irrigation | Arm Label: Saline, Low Pressure; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Saline Solution, Procedure: Low Pressure Irrigation | Arm Label: Saline, High Pressure; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Saline Solution, Procedure: High Pressure | Arm Label: Soap, Gravity Flow; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Soap solution, Procedure: Gravity Flow Irrigation | Arm Label: Soap, low pressure; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Soap solution, Procedure: Low Pressure Irrigation | Arm Label: Soap, high pressure; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Soap solution, Procedure: High Pressure | Intervention Type: PROCEDURE; Name: Saline Solution; Assigned to Arm(s): Saline, High Pressure, Saline, Low Pressure, Saline, gravity flow | Intervention Type: PROCEDURE; Name: Soap solution; Assigned to Arm(s): Soap, Gravity Flow, Soap, high pressure, Soap, low pressure | Intervention Type: PROCEDURE; Name: Gravity Flow Irrigation; Assigned to Arm(s): Saline, gravity flow, Soap, Gravity Flow | Intervention Type: PROCEDURE; Name: Low Pressure Irrigation; Assigned to Arm(s): Saline, Low Pressure, Soap, low pressure | Intervention Type: PROCEDURE; Name: High Pressure; Assigned to Arm(s): Saline, High Pressure, Soap, high pressure

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The effect of axillary lavage with a gentamicin solution before wound closure will reduce the drainage volume and subsequently day of drainage removal.


Options:
A: Arm Label: Treatment Arm; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cefazolin | Arm Label: Placebo Arm; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Sterile water | Intervention Type: PROCEDURE; Name: Cefazolin; Assigned to Arm(s): Treatment Arm | Intervention Type: PROCEDURE; Name: Sterile water; Assigned to Arm(s): Placebo Arm
B: Arm Label: Prophylaxis Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ampicillin/Sulbactam | Arm Label: No Prophylaxis Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Ampicillin/Sulbactam; Assigned to Arm(s): Prophylaxis Group
C: Arm Label: Gentamicin lavage; Type: EXPERIMENTAL; Interventions: Drug: Axillary lavage with gentamicin solution | Arm Label: Normal saline lavage; Type: ACTIVE_COMPARATOR; Interventions: Drug: Axillary lavage with gentamicin solution | Intervention Type: DRUG; Name: Axillary lavage with gentamicin solution; Assigned to Arm(s): Gentamicin lavage, Normal saline lavage
D: Arm Label: Antibiotics until Drain Removal; Type: OTHER; Interventions: Drug: Cefadroxil until drain removal | Arm Label: Early discontinuation of antibiotics; Type: EXPERIMENTAL; Interventions: Drug: Cefadroxil discontinued early | Intervention Type: DRUG; Name: Cefadroxil discontinued early; Assigned to Arm(s): Early discontinuation of antibiotics | Intervention Type: DRUG; Name: Cefadroxil until drain removal; Assigned to Arm(s): Antibiotics until Drain Removal

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial to Improve Support Services for Caregivers of Patients With Alzheimer Disease in Italy by UPgrading Quality of Care Through the Integration of Services and the Use of New TECHnologies (The UP-TECH Project)
Brief Summary: The UP-TECH project aims at developing an UPgrading quality of care for Alzheimer's disease patients through the integration of services and the use of new TECHnologies in order to also improving the quality of life of their family caregivers.


Options:
A: Arm Label: Psycho-educational program; Type: EXPERIMENTAL; Interventions: Behavioral: psycho-social intervention based on a web-based psycho-educational program, called Diapason. | Arm Label: Standard treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Consultation in memory clinic | Intervention Type: BEHAVIORAL; Name: psycho-social intervention based on a web-based psycho-educational program, called Diapason.; Assigned to Arm(s): Psycho-educational program | Intervention Type: BEHAVIORAL; Name: Consultation in memory clinic; Assigned to Arm(s): Standard treatment
B: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: structured support groups | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: structured support groups; Assigned to Arm(s): intervention
C: Arm Label: Immediately Receive Tool; Type: EXPERIMENTAL; Interventions: Behavioral: Immediately Receive Tool | Arm Label: One Month Delay; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: One Month Delay | Intervention Type: BEHAVIORAL; Name: Immediately Receive Tool; Assigned to Arm(s): Immediately Receive Tool | Intervention Type: BEHAVIORAL; Name: One Month Delay; Assigned to Arm(s): One Month Delay
D: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: light support, Other: 3 preventive home visits by a nurse | Arm Label: UP Protocol; Type: EXPERIMENTAL; Interventions: Other: Case Manager, Other: 3 preventive home visits by a nurse | Arm Label: UP-TECH Protocol; Type: EXPERIMENTAL; Interventions: Other: Case Manager, Other: Assistive Technologies, Other: 3 preventive home visits by a nurse | Intervention Type: OTHER; Name: Case Manager; Assigned to Arm(s): UP Protocol, UP-TECH Protocol | Intervention Type: OTHER; Name: Assistive Technologies; Assigned to Arm(s): UP-TECH Protocol | Intervention Type: OTHER; Name: light support; Assigned to Arm(s): Usual Care | Intervention Type: OTHER; Name: 3 preventive home visits by a nurse; Assigned to Arm(s): UP Protocol, UP-TECH Protocol, Usual Care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial to Improve Support Services for Caregivers of Patients With Alzheimer Disease in Italy by UPgrading Quality of Care Through the Integration of Services and the Use of New TECHnologies (The UP-TECH Project)
Brief Summary: The UP-TECH project aims at developing an UPgrading quality of care for Alzheimer's disease patients through the integration of services and the use of new TECHnologies in order to also improving the quality of life of their family caregivers.


Options:
A: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: light support, Other: 3 preventive home visits by a nurse | Arm Label: UP Protocol; Type: EXPERIMENTAL; Interventions: Other: Case Manager, Other: 3 preventive home visits by a nurse | Arm Label: UP-TECH Protocol; Type: EXPERIMENTAL; Interventions: Other: Case Manager, Other: Assistive Technologies, Other: 3 preventive home visits by a nurse | Intervention Type: OTHER; Name: Case Manager; Assigned to Arm(s): UP Protocol, UP-TECH Protocol | Intervention Type: OTHER; Name: Assistive Technologies; Assigned to Arm(s): UP-TECH Protocol | Intervention Type: OTHER; Name: light support; Assigned to Arm(s): Usual Care | Intervention Type: OTHER; Name: 3 preventive home visits by a nurse; Assigned to Arm(s): UP Protocol, UP-TECH Protocol, Usual Care
B: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: structured support groups | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: structured support groups; Assigned to Arm(s): intervention
C: Arm Label: iSupport for dementia - European-Portuguese version; Type: EXPERIMENTAL; Interventions: Behavioral: iSupport for dementia - European-Portuguese version | Arm Label: Education-only e-book; Type: ACTIVE_COMPARATOR; Interventions: Other: e-book (comparator) | Intervention Type: BEHAVIORAL; Name: iSupport for dementia - European-Portuguese version; Assigned to Arm(s): iSupport for dementia - European-Portuguese version | Intervention Type: OTHER; Name: e-book (comparator); Assigned to Arm(s): Education-only e-book
D: Arm Label: Active treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Video-based coping skills training with telephone coaching | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Video-based coping skills training with telephone coaching; Assigned to Arm(s): Active treatment

Answer: A